In pharmaceuticals, success isn’t only about scientific breakthroughs. It also depends on strategy. Competitive intelligence enables companies to track pipelines, market moves, and regulatory shifts, helping them make smarter decisions from development to commercialization.
It plays a role in refining drug development, improving due diligence in partnerships, differentiating brands, optimizing portfolios, and navigating market dynamics with agility.
The challenges are real—accessing reliable data, finding the right talent, avoiding information overload, and maintaining ethical standards in data collection. Yet, when done well, competitive intelligence becomes more than an add-on. It’s a strategic necessity.
Is competitive intelligence being treated as central to pharma strategy in your experience, or still as a supporting function?
Top comments (0)